封面
市场调查报告书
商品编码
1455085

全球插管系统市场规模、份额、成长分析(按类型、按应用) - 产业预测,2024-2031 年

Global Cannula System Market Size, Share, Growth Analysis, By Type(Dermatology Cannulas, Cardiac Cannulas), By Application(Cardiovascular Surgery, Plastic Surgery) - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球插管系统市场规模为150.8亿美元,将从2023年的165.7亿美元成长到2031年的352亿美元,预测期间(2024-2031年)复合年增长率为9.90%。成长至7000万美元。

推动全球插管系统市场的关键因素之一是糖尿病(尤其是第 2 型糖尿病)盛行率的上升,这推动了对精确有效的血糖监测解决方案的需求。此外,糖尿病患者对定期血糖监测重要性的认识不断提高,正在推动市场扩张。技术进步,尤其是连续血糖监测 (CGM) 系统,对于推动市场向前发展至关重要。这些提供即时血糖测量的创新技术因其准确性、便利性的提高以及糖尿病患者血糖管理的改善而获得了相当大的关注。此外,智慧型手机连接和资料分析功能等先进功能正在改善用户体验并推动市场成长。

目录

执行摘要

  • 市场概况
  • 繁荣与衰落

调查方法

  • 资讯采购
  • 次要和主要资料来源
  • 市场规模估算
  • 市场假设与限制

母市场分析

  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务

主要市场考察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • Start-Ups分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

市场动态及前景

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 监管环境
  • 波特的分析
  • 对未来中断的特殊考虑

插管系统的全球市场:按类型

  • 市场概况
  • 皮肤科插管
  • 心臟插管
  • 关节镜
  • 氧气鼻管
  • 血管插管
  • 其他的

插管系统的全球市场:依应用分类

  • 市场概况
  • 心血管外科
  • 整形外科
  • 整形外科
  • 一般外科
  • 整容手术
  • 其他的

插管系统的全球市场规模:按地区

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东/非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位(2021年)
  • 主要市场参与者所采取的策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率(2021年)

主要企业简介

  • 美敦力(爱尔兰)
  • 强生公司(美国)
  • 贝克顿迪金森公司(美国)
  • 泰利福公司(美国)
  • 史密斯医疗(英国)
  • 泰尔茂株式会社(日本)
  • 爱德华兹生命科学公司(美国)
  • CONMED公司(美国)
  • 波士顿科学公司(美国)
  • B.Braun Melsungen AG(德国)
  • 库克医疗(美国)
  • Merit 医疗系统公司(美国)
  • 维贡(法国)
  • 尼普罗医疗株式会社(日本)
  • 血管动力学公司(美国)
  • 罗姆森工业集团(印度)
  • Medline Industries, Inc.(美国)
  • 维立医疗股份有限公司 (中国)
  • Global Medikit 有限公司(印度)
  • 施乐辉公司(英国)
简介目录
Product Code: SQMIG35J2056

Global Cannula System Market size was valued at USD 15.08 Billion in 2022 and is poised to grow from USD 16.57 Billion in 2023 to USD 35.27 Billion by 2031, at a CAGR of 9.90% during the forecast period (2024-2031).

One of the main factors propelling the global cannula market forward is the escalating prevalence of diabetes, particularly type 2 diabetes, which is driving the demand for precise and effective blood glucose monitoring solutions. Moreover, the increasing awareness among diabetic patients regarding the significance of regular glucose monitoring is bolstering market expansion. Technological advancements, notably continuous glucose monitoring (CGM) systems, are pivotal in driving the market forward. These innovations, offering real-time glucose readings, have garnered considerable traction due to their enhanced accuracy, convenience, and improved glucose management for individuals with diabetes. Furthermore, the incorporation of advanced features such as smartphone connectivity and data analysis capabilities is augmenting user experience and fostering market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cannula System Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cannula System Market Segmental Analysis

The global cannula market is segmented based on type, application, and region. Based on type, the market can be segmented into dermatology cannulas, cardiac cannulas, arthroscopy cannulas, nasal cannulas, vascular cannulas, and others. Based on application, the market is segmented into cardiovascular surgery, plastic surgery, orthopedic surgery, general surgery, cosmetology, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Midd in 2022.

Drivers of the Global Cannula System Market

The increasing demand for minimally invasive surgical procedures such as laparoscopy, arthroscopy, and cosmetic surgeries is fueling growth in the global cannulas market. The shift towards these techniques over traditional open surgeries is propelling the uptake of cannulas, driven by their associated benefits such as smaller incisions, faster recovery times, decreased pain, and fewer postoperative complications. This trend is resulting in a heightened utilization of cannulas across various medical fields.

Restraints in the Global Cannula System Market

The demand for cannulas in certain scenarios can be influenced by the accessibility of alternative medical devices or procedures. Progress in drug delivery methods like oral medications or transdermal patches can diminish the requirement for particular types of cannulas. The presence of alternative treatment options may constrain the expansion of the cannulas market in specific applications, as healthcare providers seek alternative methods to attain similar results.

Market Trends of the Global Cannula System Market

A significant trend in the medical field is the rising acceptance of minimally invasive surgical methods, fueling a surge in the need for specialized cannulas. These techniques offer numerous benefits including smaller incisions, diminished scarring, quicker recovery periods, and reduced complication risks. Consequently, medical professionals are in search of cannulas that allow for accurate and controlled entry to specific areas with minimal tissue damage. In response, manufacturers are innovating cannulas with features like smaller sizes, flexible structures, and enhanced maneuverability, making them ideal for minimally invasive procedures.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Cannula System Market by Type

  • Market Overview
  • Dermatology Cannulas
  • Cardiac Cannulas
  • Arthroscopy Cannulas
  • Nasal Cannulas
  • Vascular Cannulas
  • and Others.

Global Cannula System Market by Application

  • Market Overview
  • Cardiovascular Surgery
  • Plastic Surgery
  • Orthopedic Surgery
  • General Surgery
  • Cosmetology
  • and Others.

Global Cannula System Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Medical (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CONMED Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vygon (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Medical Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Romsons Group of Industries (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Well Lead Medical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Global Medikit Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments